Tracer Level Electrophilic Synthesis and Pharmacokinetics of the Hypoxia Tracer [18F]EF5 View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2012-04

AUTHORS

Olli Eskola, Tove J. Grönroos, Sarita Forsback, Johanna Tuomela, Gaber Komar, Jörgen Bergman, Pirkko Härkönen, Merja Haaparanta, Heikki Minn, Olof Solin

ABSTRACT

PURPOSE: 2-(2-nitro-1H-imidazol-1-yl)-N-(2,2,3,3,3-pentafluoropropyl)-acetamide labeled with [(18)F]-fluorine ([(18)F]EF5), a promising tracer for tumor hypoxia, has previously been synthesized in low yields and low specific radioactivity. In pharmacokinetic evaluations, in the presence of non-radioactive EF5, a uniform and low background uptake and high in vivo stability of [(18)F]EF5 have been demonstrated. Our purpose was to increase the specific radioactivity of [(18)F]EF5 to enable to study the pharmacokinetics at trace level. PROCEDURES: [(18)F]EF5 was synthesized using high specific radioactivity electrophilic [(18)F]F(2) as labelling reagent. Biodistribution of [(18)F]EF5 was determined in a prostate tumor mouse model, and formation of radiolabelled metabolites was studied in mouse, rat and human plasma. RESULTS: On average, 595 ± 153 MBq of [(18)F]EF5 was produced. Specific radioactivity was 6.6 ± 1.9 GBq/μmol and the radiochemical purity exceeded 99.0%. [(18)F]EF5 was distributed uniformly in tissues, with highest uptake in liver, kidney, and intestine. Several radiolabelled metabolites were detected in mouse plasma and tissues, whereas low amounts of metabolites were detected in human and rat plasma. CONCLUSIONS: [(18)F]EF5 was synthesized by electrophilic labelling with high quality and high yields. Pharmacokinetics of [(18)F]EF5 was determined at trace level in several species. Our results suggest that the trace-level approach does not affect the biodistribution of [(18)F]EF5. Extensive metabolism was seen in mouse. More... »

PAGES

205-212

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s11307-011-0484-4

DOI

http://dx.doi.org/10.1007/s11307-011-0484-4

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1046913665

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/21448777


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Oncology and Carcinogenesis", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Animals", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cell Hypoxia", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cell Line, Tumor", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Chromatography, High Pressure Liquid", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Chromatography, Thin Layer", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Etanidazole", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Fluorine Radioisotopes", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Hydrocarbons, Fluorinated", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Isomerism", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Mice", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Radioactive Tracers", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Rats", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Tissue Distribution", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Xenograft Model Antitumor Assays", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Turku PET Centre", 
          "id": "https://www.grid.ac/institutes/grid.470895.7", 
          "name": [
            "Turku PET Centre, Radiopharmaceutical Chemistry Laboratory, University of Turku, Turku, Finland"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Eskola", 
        "givenName": "Olli", 
        "id": "sg:person.01310420600.55", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01310420600.55"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Turku PET Centre", 
          "id": "https://www.grid.ac/institutes/grid.470895.7", 
          "name": [
            "Turku PET Centre, Medicity/PET Preclinical Imaging, University of Turku, Turku, Finland"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Gr\u00f6nroos", 
        "givenName": "Tove J.", 
        "id": "sg:person.01102756462.43", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01102756462.43"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Turku PET Centre", 
          "id": "https://www.grid.ac/institutes/grid.470895.7", 
          "name": [
            "Turku PET Centre, Radiopharmaceutical Chemistry Laboratory, University of Turku, Turku, Finland"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Forsback", 
        "givenName": "Sarita", 
        "id": "sg:person.01071362053.45", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01071362053.45"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Pharmatest (Finland)", 
          "id": "https://www.grid.ac/institutes/grid.452714.1", 
          "name": [
            "Department of Cell Biology and Anatomy, Institute of Biomedicine, University of Turku, Turku, Finland", 
            "Pharmatest Services Ltd, Turku, Finland"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Tuomela", 
        "givenName": "Johanna", 
        "id": "sg:person.01244231205.07", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01244231205.07"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University of Turku", 
          "id": "https://www.grid.ac/institutes/grid.1374.1", 
          "name": [
            "Department of Oncology and Radiotherapy and Turku PET Centre, University of Turku, Turku, Finland"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Komar", 
        "givenName": "Gaber", 
        "id": "sg:person.01045317743.33", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01045317743.33"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Turku PET Centre", 
          "id": "https://www.grid.ac/institutes/grid.470895.7", 
          "name": [
            "Turku PET Centre, Radiopharmaceutical Chemistry Laboratory, University of Turku, Turku, Finland", 
            "Turku PET Centre, Accelerator Laboratory, \u00c5bo Akademi University, Turku, Finland"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Bergman", 
        "givenName": "J\u00f6rgen", 
        "id": "sg:person.011221263002.14", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011221263002.14"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Lund University", 
          "id": "https://www.grid.ac/institutes/grid.4514.4", 
          "name": [
            "Department of Cell Biology and Anatomy, Institute of Biomedicine, University of Turku, Turku, Finland", 
            "Department of Laboratory Medicine, MAS University Hospital, Lund University, Lund, Sweden"
          ], 
          "type": "Organization"
        }, 
        "familyName": "H\u00e4rk\u00f6nen", 
        "givenName": "Pirkko", 
        "id": "sg:person.01131663575.79", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01131663575.79"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Turku PET Centre", 
          "id": "https://www.grid.ac/institutes/grid.470895.7", 
          "name": [
            "Turku PET Centre, Medicity/PET Preclinical Imaging, University of Turku, Turku, Finland"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Haaparanta", 
        "givenName": "Merja", 
        "id": "sg:person.01205342410.46", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01205342410.46"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University of Turku", 
          "id": "https://www.grid.ac/institutes/grid.1374.1", 
          "name": [
            "Department of Oncology and Radiotherapy and Turku PET Centre, University of Turku, Turku, Finland"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Minn", 
        "givenName": "Heikki", 
        "id": "sg:person.0700413711.55", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0700413711.55"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Turku PET Centre", 
          "id": "https://www.grid.ac/institutes/grid.470895.7", 
          "name": [
            "Turku PET Centre, Radiopharmaceutical Chemistry Laboratory, University of Turku, Turku, Finland", 
            "Turku PET Centre, Accelerator Laboratory, \u00c5bo Akademi University, Turku, Finland"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Solin", 
        "givenName": "Olof", 
        "id": "sg:person.0656631675.01", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0656631675.01"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1007/s002800100324", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1002101901", 
          "https://doi.org/10.1007/s002800100324"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.cpet.2009.05.009", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1009053004"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0304-3835(03)00012-0", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1013725216"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0304-3835(03)00012-0", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1013725216"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf01081524", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1020842283", 
          "https://doi.org/10.1007/bf01081524"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf01081524", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1020842283", 
          "https://doi.org/10.1007/bf01081524"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0969-8043(00)00102-0", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1022402045"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.2967/jnumed.108.053785", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1023439730"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00259-008-0907-x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1023774517", 
          "https://doi.org/10.1007/s00259-008-0907-x"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00259-008-0907-x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1023774517", 
          "https://doi.org/10.1007/s00259-008-0907-x"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0969-8051(97)00078-4", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1027245422"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00259-002-1037-5", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1029511921", 
          "https://doi.org/10.1007/s00259-002-1037-5"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/978-1-4615-0205-0_47", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1030408834", 
          "https://doi.org/10.1007/978-1-4615-0205-0_47"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/978-1-4615-0205-0_47", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1030408834", 
          "https://doi.org/10.1007/978-1-4615-0205-0_47"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.clon.2007.03.001", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1036359571"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.2967/jnumed.108.053751", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1036581427"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00259-004-1573-2", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1039480227", 
          "https://doi.org/10.1007/s00259-004-1573-2"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nrc1367", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1052255963", 
          "https://doi.org/10.1038/nrc1367"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nrc1367", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1052255963", 
          "https://doi.org/10.1038/nrc1367"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.2967/jnumed.107.045914", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1052989114"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.2174/138161208786404380", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1069166739"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1074595031", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1082884525", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1083365125", 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2012-04", 
    "datePublishedReg": "2012-04-01", 
    "description": "PURPOSE: 2-(2-nitro-1H-imidazol-1-yl)-N-(2,2,3,3,3-pentafluoropropyl)-acetamide labeled with [(18)F]-fluorine ([(18)F]EF5), a promising tracer for tumor hypoxia, has previously been synthesized in low yields and low specific radioactivity. In pharmacokinetic evaluations, in the presence of non-radioactive EF5, a uniform and low background uptake and high in vivo stability of [(18)F]EF5 have been demonstrated. Our purpose was to increase the specific radioactivity of [(18)F]EF5 to enable to study the pharmacokinetics at trace level.\nPROCEDURES: [(18)F]EF5 was synthesized using high specific radioactivity electrophilic [(18)F]F(2) as labelling reagent. Biodistribution of [(18)F]EF5 was determined in a prostate tumor mouse model, and formation of radiolabelled metabolites was studied in mouse, rat and human plasma.\nRESULTS: On average, 595\u2009\u00b1\u2009153 MBq of [(18)F]EF5 was produced. Specific radioactivity was 6.6\u2009\u00b1\u20091.9 GBq/\u03bcmol and the radiochemical purity exceeded 99.0%. [(18)F]EF5 was distributed uniformly in tissues, with highest uptake in liver, kidney, and intestine. Several radiolabelled metabolites were detected in mouse plasma and tissues, whereas low amounts of metabolites were detected in human and rat plasma.\nCONCLUSIONS: [(18)F]EF5 was synthesized by electrophilic labelling with high quality and high yields. Pharmacokinetics of [(18)F]EF5 was determined at trace level in several species. Our results suggest that the trace-level approach does not affect the biodistribution of [(18)F]EF5. Extensive metabolism was seen in mouse.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1007/s11307-011-0484-4", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1118463", 
        "issn": [
          "1536-1632", 
          "1878-5751"
        ], 
        "name": "Molecular Imaging and Biology", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "2", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "14"
      }
    ], 
    "name": "Tracer Level Electrophilic Synthesis and Pharmacokinetics of the Hypoxia Tracer [18F]EF5", 
    "pagination": "205-212", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "df7abd72844c90080e3a16addb2e4c1560c97cf3823e06f758b324c39454ab66"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "21448777"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "101125610"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s11307-011-0484-4"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1046913665"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s11307-011-0484-4", 
      "https://app.dimensions.ai/details/publication/pub.1046913665"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-10T15:04", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000001_0000000264/records_8663_00000524.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "http://link.springer.com/10.1007%2Fs11307-011-0484-4"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s11307-011-0484-4'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s11307-011-0484-4'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s11307-011-0484-4'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s11307-011-0484-4'


 

This table displays all metadata directly associated to this object as RDF triples.

270 TRIPLES      21 PREDICATES      64 URIs      37 LITERALS      25 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s11307-011-0484-4 schema:about N18825248fe8a4789847bb406cc3e85b8
2 N2002c7d6ce004797a544844d8f27ebde
3 N2ed655c080c74c96a9c30a3fc8e91d9b
4 N40230c6266be448292d3ae38a788c9fe
5 N5015849d1f5244299a303dabb3b4bd73
6 N519782d7183643689870438b3bd91aae
7 N55027fe3612942609b5f7a70c06fda03
8 N552ab55277fa447896b200639ced5732
9 N57128e2d504141ffb3ae3d223af53d06
10 N7d8f83e3ccbc4ad9888a940aebb1c919
11 N86fa39f748f9481abbf9a7f75d75ee9d
12 Na30c9ba0e5114cd1b325286535a7e5b7
13 Nabe20bcd3d3549c8a9431e30adf014eb
14 Ncd5071596a30438a9a1513df736e7415
15 Ndeacf0dc0a3c4ca2aad3c073f7d401b3
16 Ne346998a07f245fb8db2aae85d3b9b24
17 anzsrc-for:11
18 anzsrc-for:1112
19 schema:author N3f9102422fc64b3bbbc161ff43378843
20 schema:citation sg:pub.10.1007/978-1-4615-0205-0_47
21 sg:pub.10.1007/bf01081524
22 sg:pub.10.1007/s00259-002-1037-5
23 sg:pub.10.1007/s00259-004-1573-2
24 sg:pub.10.1007/s00259-008-0907-x
25 sg:pub.10.1007/s002800100324
26 sg:pub.10.1038/nrc1367
27 https://app.dimensions.ai/details/publication/pub.1074595031
28 https://app.dimensions.ai/details/publication/pub.1082884525
29 https://app.dimensions.ai/details/publication/pub.1083365125
30 https://doi.org/10.1016/j.clon.2007.03.001
31 https://doi.org/10.1016/j.cpet.2009.05.009
32 https://doi.org/10.1016/s0304-3835(03)00012-0
33 https://doi.org/10.1016/s0969-8043(00)00102-0
34 https://doi.org/10.1016/s0969-8051(97)00078-4
35 https://doi.org/10.2174/138161208786404380
36 https://doi.org/10.2967/jnumed.107.045914
37 https://doi.org/10.2967/jnumed.108.053751
38 https://doi.org/10.2967/jnumed.108.053785
39 schema:datePublished 2012-04
40 schema:datePublishedReg 2012-04-01
41 schema:description PURPOSE: 2-(2-nitro-1H-imidazol-1-yl)-N-(2,2,3,3,3-pentafluoropropyl)-acetamide labeled with [(18)F]-fluorine ([(18)F]EF5), a promising tracer for tumor hypoxia, has previously been synthesized in low yields and low specific radioactivity. In pharmacokinetic evaluations, in the presence of non-radioactive EF5, a uniform and low background uptake and high in vivo stability of [(18)F]EF5 have been demonstrated. Our purpose was to increase the specific radioactivity of [(18)F]EF5 to enable to study the pharmacokinetics at trace level. PROCEDURES: [(18)F]EF5 was synthesized using high specific radioactivity electrophilic [(18)F]F(2) as labelling reagent. Biodistribution of [(18)F]EF5 was determined in a prostate tumor mouse model, and formation of radiolabelled metabolites was studied in mouse, rat and human plasma. RESULTS: On average, 595 ± 153 MBq of [(18)F]EF5 was produced. Specific radioactivity was 6.6 ± 1.9 GBq/μmol and the radiochemical purity exceeded 99.0%. [(18)F]EF5 was distributed uniformly in tissues, with highest uptake in liver, kidney, and intestine. Several radiolabelled metabolites were detected in mouse plasma and tissues, whereas low amounts of metabolites were detected in human and rat plasma. CONCLUSIONS: [(18)F]EF5 was synthesized by electrophilic labelling with high quality and high yields. Pharmacokinetics of [(18)F]EF5 was determined at trace level in several species. Our results suggest that the trace-level approach does not affect the biodistribution of [(18)F]EF5. Extensive metabolism was seen in mouse.
42 schema:genre research_article
43 schema:inLanguage en
44 schema:isAccessibleForFree false
45 schema:isPartOf N242bc3c53fa343afa0abfdfc5ecc5d07
46 N4b3fd698c2334954bec4ace3ceef5ff9
47 sg:journal.1118463
48 schema:name Tracer Level Electrophilic Synthesis and Pharmacokinetics of the Hypoxia Tracer [18F]EF5
49 schema:pagination 205-212
50 schema:productId N211fc461fa48445f9255d3fd27dbfb6a
51 N22c6dde774a74f9d9f4f72ff917dee60
52 N577cdb4948384e5c81a6f874da511b48
53 Nf0063d456b0f471faf53e23b2e500c55
54 Nfdb090f59b484c2e854af577c45d5eda
55 schema:sameAs https://app.dimensions.ai/details/publication/pub.1046913665
56 https://doi.org/10.1007/s11307-011-0484-4
57 schema:sdDatePublished 2019-04-10T15:04
58 schema:sdLicense https://scigraph.springernature.com/explorer/license/
59 schema:sdPublisher N203e82fa021c4eb496bdbeb5d7ff93ff
60 schema:url http://link.springer.com/10.1007%2Fs11307-011-0484-4
61 sgo:license sg:explorer/license/
62 sgo:sdDataset articles
63 rdf:type schema:ScholarlyArticle
64 N0f410571892e421a83db91805d2015f5 rdf:first sg:person.0656631675.01
65 rdf:rest rdf:nil
66 N18825248fe8a4789847bb406cc3e85b8 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
67 schema:name Chromatography, Thin Layer
68 rdf:type schema:DefinedTerm
69 N1de050ce90c04fa589bf0b5f2b134a9e rdf:first sg:person.01131663575.79
70 rdf:rest N67ec31117d6349e88debf110115b9e65
71 N2002c7d6ce004797a544844d8f27ebde schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
72 schema:name Fluorine Radioisotopes
73 rdf:type schema:DefinedTerm
74 N203e82fa021c4eb496bdbeb5d7ff93ff schema:name Springer Nature - SN SciGraph project
75 rdf:type schema:Organization
76 N211fc461fa48445f9255d3fd27dbfb6a schema:name pubmed_id
77 schema:value 21448777
78 rdf:type schema:PropertyValue
79 N22c6dde774a74f9d9f4f72ff917dee60 schema:name dimensions_id
80 schema:value pub.1046913665
81 rdf:type schema:PropertyValue
82 N242bc3c53fa343afa0abfdfc5ecc5d07 schema:issueNumber 2
83 rdf:type schema:PublicationIssue
84 N2ed655c080c74c96a9c30a3fc8e91d9b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
85 schema:name Humans
86 rdf:type schema:DefinedTerm
87 N3f9102422fc64b3bbbc161ff43378843 rdf:first sg:person.01310420600.55
88 rdf:rest N6e24094b49ac4fa0b8bca523f81f1687
89 N40230c6266be448292d3ae38a788c9fe schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
90 schema:name Xenograft Model Antitumor Assays
91 rdf:type schema:DefinedTerm
92 N4b3fd698c2334954bec4ace3ceef5ff9 schema:volumeNumber 14
93 rdf:type schema:PublicationVolume
94 N5015849d1f5244299a303dabb3b4bd73 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
95 schema:name Male
96 rdf:type schema:DefinedTerm
97 N519782d7183643689870438b3bd91aae schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
98 schema:name Radioactive Tracers
99 rdf:type schema:DefinedTerm
100 N55027fe3612942609b5f7a70c06fda03 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
101 schema:name Hydrocarbons, Fluorinated
102 rdf:type schema:DefinedTerm
103 N552ab55277fa447896b200639ced5732 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
104 schema:name Cell Hypoxia
105 rdf:type schema:DefinedTerm
106 N57128e2d504141ffb3ae3d223af53d06 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
107 schema:name Isomerism
108 rdf:type schema:DefinedTerm
109 N577cdb4948384e5c81a6f874da511b48 schema:name readcube_id
110 schema:value df7abd72844c90080e3a16addb2e4c1560c97cf3823e06f758b324c39454ab66
111 rdf:type schema:PropertyValue
112 N67d3315b14b04a58b73c3738d5ac0acd rdf:first sg:person.011221263002.14
113 rdf:rest N1de050ce90c04fa589bf0b5f2b134a9e
114 N67ec31117d6349e88debf110115b9e65 rdf:first sg:person.01205342410.46
115 rdf:rest Ncda8b1cf00924a568f32267b5f9cc5d7
116 N6e24094b49ac4fa0b8bca523f81f1687 rdf:first sg:person.01102756462.43
117 rdf:rest N9df3fbf87129445da8b275f7d2dc06fa
118 N7d8f83e3ccbc4ad9888a940aebb1c919 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
119 schema:name Mice
120 rdf:type schema:DefinedTerm
121 N86fa39f748f9481abbf9a7f75d75ee9d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
122 schema:name Tissue Distribution
123 rdf:type schema:DefinedTerm
124 N9df3fbf87129445da8b275f7d2dc06fa rdf:first sg:person.01071362053.45
125 rdf:rest Ne6097a0caa7a4ab587e5c3a6bf443dc5
126 Na30c9ba0e5114cd1b325286535a7e5b7 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
127 schema:name Chromatography, High Pressure Liquid
128 rdf:type schema:DefinedTerm
129 Nabe20bcd3d3549c8a9431e30adf014eb schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
130 schema:name Animals
131 rdf:type schema:DefinedTerm
132 Ncd5071596a30438a9a1513df736e7415 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
133 schema:name Rats
134 rdf:type schema:DefinedTerm
135 Ncda8b1cf00924a568f32267b5f9cc5d7 rdf:first sg:person.0700413711.55
136 rdf:rest N0f410571892e421a83db91805d2015f5
137 Ndeacf0dc0a3c4ca2aad3c073f7d401b3 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
138 schema:name Cell Line, Tumor
139 rdf:type schema:DefinedTerm
140 Ne346998a07f245fb8db2aae85d3b9b24 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
141 schema:name Etanidazole
142 rdf:type schema:DefinedTerm
143 Ne6097a0caa7a4ab587e5c3a6bf443dc5 rdf:first sg:person.01244231205.07
144 rdf:rest Nfa3679789d9c44d38a8f4cc17e3cc45a
145 Nf0063d456b0f471faf53e23b2e500c55 schema:name nlm_unique_id
146 schema:value 101125610
147 rdf:type schema:PropertyValue
148 Nfa3679789d9c44d38a8f4cc17e3cc45a rdf:first sg:person.01045317743.33
149 rdf:rest N67d3315b14b04a58b73c3738d5ac0acd
150 Nfdb090f59b484c2e854af577c45d5eda schema:name doi
151 schema:value 10.1007/s11307-011-0484-4
152 rdf:type schema:PropertyValue
153 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
154 schema:name Medical and Health Sciences
155 rdf:type schema:DefinedTerm
156 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
157 schema:name Oncology and Carcinogenesis
158 rdf:type schema:DefinedTerm
159 sg:journal.1118463 schema:issn 1536-1632
160 1878-5751
161 schema:name Molecular Imaging and Biology
162 rdf:type schema:Periodical
163 sg:person.01045317743.33 schema:affiliation https://www.grid.ac/institutes/grid.1374.1
164 schema:familyName Komar
165 schema:givenName Gaber
166 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01045317743.33
167 rdf:type schema:Person
168 sg:person.01071362053.45 schema:affiliation https://www.grid.ac/institutes/grid.470895.7
169 schema:familyName Forsback
170 schema:givenName Sarita
171 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01071362053.45
172 rdf:type schema:Person
173 sg:person.01102756462.43 schema:affiliation https://www.grid.ac/institutes/grid.470895.7
174 schema:familyName Grönroos
175 schema:givenName Tove J.
176 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01102756462.43
177 rdf:type schema:Person
178 sg:person.011221263002.14 schema:affiliation https://www.grid.ac/institutes/grid.470895.7
179 schema:familyName Bergman
180 schema:givenName Jörgen
181 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011221263002.14
182 rdf:type schema:Person
183 sg:person.01131663575.79 schema:affiliation https://www.grid.ac/institutes/grid.4514.4
184 schema:familyName Härkönen
185 schema:givenName Pirkko
186 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01131663575.79
187 rdf:type schema:Person
188 sg:person.01205342410.46 schema:affiliation https://www.grid.ac/institutes/grid.470895.7
189 schema:familyName Haaparanta
190 schema:givenName Merja
191 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01205342410.46
192 rdf:type schema:Person
193 sg:person.01244231205.07 schema:affiliation https://www.grid.ac/institutes/grid.452714.1
194 schema:familyName Tuomela
195 schema:givenName Johanna
196 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01244231205.07
197 rdf:type schema:Person
198 sg:person.01310420600.55 schema:affiliation https://www.grid.ac/institutes/grid.470895.7
199 schema:familyName Eskola
200 schema:givenName Olli
201 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01310420600.55
202 rdf:type schema:Person
203 sg:person.0656631675.01 schema:affiliation https://www.grid.ac/institutes/grid.470895.7
204 schema:familyName Solin
205 schema:givenName Olof
206 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0656631675.01
207 rdf:type schema:Person
208 sg:person.0700413711.55 schema:affiliation https://www.grid.ac/institutes/grid.1374.1
209 schema:familyName Minn
210 schema:givenName Heikki
211 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0700413711.55
212 rdf:type schema:Person
213 sg:pub.10.1007/978-1-4615-0205-0_47 schema:sameAs https://app.dimensions.ai/details/publication/pub.1030408834
214 https://doi.org/10.1007/978-1-4615-0205-0_47
215 rdf:type schema:CreativeWork
216 sg:pub.10.1007/bf01081524 schema:sameAs https://app.dimensions.ai/details/publication/pub.1020842283
217 https://doi.org/10.1007/bf01081524
218 rdf:type schema:CreativeWork
219 sg:pub.10.1007/s00259-002-1037-5 schema:sameAs https://app.dimensions.ai/details/publication/pub.1029511921
220 https://doi.org/10.1007/s00259-002-1037-5
221 rdf:type schema:CreativeWork
222 sg:pub.10.1007/s00259-004-1573-2 schema:sameAs https://app.dimensions.ai/details/publication/pub.1039480227
223 https://doi.org/10.1007/s00259-004-1573-2
224 rdf:type schema:CreativeWork
225 sg:pub.10.1007/s00259-008-0907-x schema:sameAs https://app.dimensions.ai/details/publication/pub.1023774517
226 https://doi.org/10.1007/s00259-008-0907-x
227 rdf:type schema:CreativeWork
228 sg:pub.10.1007/s002800100324 schema:sameAs https://app.dimensions.ai/details/publication/pub.1002101901
229 https://doi.org/10.1007/s002800100324
230 rdf:type schema:CreativeWork
231 sg:pub.10.1038/nrc1367 schema:sameAs https://app.dimensions.ai/details/publication/pub.1052255963
232 https://doi.org/10.1038/nrc1367
233 rdf:type schema:CreativeWork
234 https://app.dimensions.ai/details/publication/pub.1074595031 schema:CreativeWork
235 https://app.dimensions.ai/details/publication/pub.1082884525 schema:CreativeWork
236 https://app.dimensions.ai/details/publication/pub.1083365125 schema:CreativeWork
237 https://doi.org/10.1016/j.clon.2007.03.001 schema:sameAs https://app.dimensions.ai/details/publication/pub.1036359571
238 rdf:type schema:CreativeWork
239 https://doi.org/10.1016/j.cpet.2009.05.009 schema:sameAs https://app.dimensions.ai/details/publication/pub.1009053004
240 rdf:type schema:CreativeWork
241 https://doi.org/10.1016/s0304-3835(03)00012-0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1013725216
242 rdf:type schema:CreativeWork
243 https://doi.org/10.1016/s0969-8043(00)00102-0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1022402045
244 rdf:type schema:CreativeWork
245 https://doi.org/10.1016/s0969-8051(97)00078-4 schema:sameAs https://app.dimensions.ai/details/publication/pub.1027245422
246 rdf:type schema:CreativeWork
247 https://doi.org/10.2174/138161208786404380 schema:sameAs https://app.dimensions.ai/details/publication/pub.1069166739
248 rdf:type schema:CreativeWork
249 https://doi.org/10.2967/jnumed.107.045914 schema:sameAs https://app.dimensions.ai/details/publication/pub.1052989114
250 rdf:type schema:CreativeWork
251 https://doi.org/10.2967/jnumed.108.053751 schema:sameAs https://app.dimensions.ai/details/publication/pub.1036581427
252 rdf:type schema:CreativeWork
253 https://doi.org/10.2967/jnumed.108.053785 schema:sameAs https://app.dimensions.ai/details/publication/pub.1023439730
254 rdf:type schema:CreativeWork
255 https://www.grid.ac/institutes/grid.1374.1 schema:alternateName University of Turku
256 schema:name Department of Oncology and Radiotherapy and Turku PET Centre, University of Turku, Turku, Finland
257 rdf:type schema:Organization
258 https://www.grid.ac/institutes/grid.4514.4 schema:alternateName Lund University
259 schema:name Department of Cell Biology and Anatomy, Institute of Biomedicine, University of Turku, Turku, Finland
260 Department of Laboratory Medicine, MAS University Hospital, Lund University, Lund, Sweden
261 rdf:type schema:Organization
262 https://www.grid.ac/institutes/grid.452714.1 schema:alternateName Pharmatest (Finland)
263 schema:name Department of Cell Biology and Anatomy, Institute of Biomedicine, University of Turku, Turku, Finland
264 Pharmatest Services Ltd, Turku, Finland
265 rdf:type schema:Organization
266 https://www.grid.ac/institutes/grid.470895.7 schema:alternateName Turku PET Centre
267 schema:name Turku PET Centre, Accelerator Laboratory, Åbo Akademi University, Turku, Finland
268 Turku PET Centre, Medicity/PET Preclinical Imaging, University of Turku, Turku, Finland
269 Turku PET Centre, Radiopharmaceutical Chemistry Laboratory, University of Turku, Turku, Finland
270 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...